CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2022
CooperCompanies (NYSE: COO) will release its fourth quarter and full year 2022 financial results on December 8, 2022, at 4:15 PM ET. A conference call to discuss these results and corporate developments will follow at 5:00 PM ET. Investors can join the call via the live dial-in number 800-715-9871, using conference ID 2291153, or through a webcast on the company’s investor relations website. A recording of the call will be available post-event until December 15, 2022.
- Upcoming release of financial results may provide insight into company performance.
- Scheduled conference call indicates active communication with investors.
- None.
SAN RAMON, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release fourth quarter and full year 2022 financial results on Thursday, December 8, 2022, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
The live dial-in number for the call is 800-715-9871. The conference ID is 2291153. A simultaneous webcast of the call will be available through the “Investor Relations” section of the CooperCompanies website at http://investor.coopercos.com. A replay of the webcast will be available approximately two hours following the event.
A recording of the call will be available beginning at 9:00 PM ET on December 8, 2022 through December 15, 2022. To hear this recording, dial 800-715-9871 and enter code 2291153.
About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of roughly 14,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
FAQ
When will CooperCompanies release its 2022 financial results?
What time is the conference call for CooperCompanies' financial results?
How can I listen to the conference call for COO's financial results?
Will there be a replay of the conference call for COO?
